Concepedia

Nicholas Spetsieris

NS

5

Publications

142

Citations

5

H-Index

2020

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

West Virginia University

Nicholas Spetsieris is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, urology, and pharmacology.

ORCID

Top concepts

Publications per year

2020–2022

5

Publications

5

Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression

Shaolong Cao, Jennifer Wang, Shuangxi Ji et al. · Nature Biotechnology · 2022 · 71 citations · Full text

Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostate

Wanfu Wu, Li Wang, Nicholas Spetsieris et al. · Proceedings of the National Academy of Sciences · 2021 · 25 citations · Full text

Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer

Nicholas Spetsieris, Myrto Boukovala, Ioannis Alafis et al. · European Journal of Cancer · 2021 · 16 citations

, , +5

A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer

Nicholas Spetsieris, Myrto Boukovala, Justin A. Weldon et al. · Clinical Genitourinary Cancer · 2020 · 15 citations · Full text

, , +8

Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC).

Eleni Efstathiou, Myrto Boukovala, Nicholas Spetsieris et al. · Journal of Clinical Oncology · 2020 · 15 citations

, , +17

Rows per page

1–5 of 5